Trials / Withdrawn
WithdrawnNCT01327664
Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
A Multicenter, Open-label Study to Evaluate the Long Term Clinical Use of Treatment With AIN457 in Patients Completing Clinical Trials Investigating AIN457 for the Treatment of Non-infectious Intermediate, Posterior or Panuveitis
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will provide patients who have completed the AIN457 Phase II and Phase III clinical trials in non-infectious uveitis continued access to treatment with AIN457 while collecting safety data and information on long term clinical use of treatment with AIN457.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AIN457 |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2014-05-01
- First posted
- 2011-04-01
- Last updated
- 2013-12-06
Source: ClinicalTrials.gov record NCT01327664. Inclusion in this directory is not an endorsement.